Home›Stock Screener›Choksi Laboratories

Choksi Laboratories Share Price Today | Stock Price & Choksi Laboratories Share Screener

CHOKSILA Healthcare Services
Live Share Price BSE
₹180.00
▼ -3.90 (-2.12%)
2026-11-20 00:00:00

As of November 20, 2026, the live Choksi Laboratories share price (BSE: CHOKSILA) is ₹180.00, down 2.12% from the previous close, with shares trading between ₹175.00 and ₹193.00 in today's trading session, and a 52-week range of ₹89.65–₹219.30. Track CHOKSILA market capitalization to gauge the company's total market size. Use the Choksi Laboratories stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Choksi Laboratories opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Over the trailing twelve months the company reported revenue of ₹49 and net income of ₹2, with EBITDA of ₹14, an operating margin of 26.0% and a profit margin of 4.1%.

Choksi Laboratories Market Cap ₹135.10 Cr.
CHOKSILA P/E Ratio (TTM) 64.10
Choksi Laboratories P/B Ratio 5.41
EPS (TTM) ₹2.82
Dividend Yield -
Debt to Equity 1.29
CHOKSILA 52 Week High ₹219.30
Choksi Laboratories 52 Week Low ₹89.65
Operating Margin 26.00%
Profit Margin 4.08%
CHOKSILA Revenue (TTM) ₹49.00
EBITDA ₹14.00
Net Income ₹2.00
Total Assets ₹72.00
Total Equity ₹26.00

Choksi Laboratories Share Price Chart

Track the current stock price of Choksi Laboratories with an interactive chart. Analyse CHOKSILA share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Choksi Laboratories stock quote in one place.

The quote of ₹180.00 sits between the 52-week low of ₹89.65 and the 52-week high of ₹219.30, and the latest session moved -2.12% from the previous close.

Choksi Laboratories Company Profile - Fundamental Screener

Screen Choksi Laboratories company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for CHOKSILA shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Healthcare sector and the Healthcare Services industry, and it trades under ISIN INE493D01013.

Company Details

Classification

Sector Healthcare
Industry Healthcare Services
Sub-Sector Healthcare Services
Segment E

Identifiers and Leadership

ISIN INE493D01013

Choksi Laboratories Balance Sheet Screener

Screen CHOKSILA balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹72, up from ₹65 in 2025.

Latest statistics put total assets at ₹72 and shareholder funds at ₹26, with a leverage ratio of 1.29.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 72 65 62 60 64 66 65 55 45 41
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 52 48 43 45 47 50 33 35 29 22

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 23 18 21 27 31 32 30 18 7 5
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 26 24 22 21 18 18 20 24 22 21
Share Capital 7 7 7 7 7 7 7 7 7 7
Reserves & Surplus 19 17 15 14 11 11 13 17 15 14

Choksi Laboratories Income Statement Screener - Profit & Revenue Analysis

Screen Choksi Laboratories income statement and profit fundamentals. Analyze CHOKSILA quarterly results. Choksi Laboratories reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹49 and net profit was ₹2, equal to earnings per unit of ₹3.00, at an operating margin of 26%.

In that period expenses were ₹36, interest cost ₹3 and tax ₹1. The next period listed, 2026-March, shows revenue of ₹46 and net profit of ₹2.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 49 46 42 37 35 30 26 29 34 31 30 22 23
Expenses 36 34 31 27 24 21 22 25 27 24 24 17 17

Operating Costs and Margins

EBITDA 14 12 11 10 11 9 5 3 8 7 6 5 6
Operating Profit % 26.00% 26.00% 27.00% 28.00% 30.00% 30.00% 16.00% 10.00% 22.00% 21.00% 17.00% 23.00% 23.00%
Depreciation 8 7 7 6 6 5 5 5 4 3 3 3 3
Interest 3 3 3 3 4 3 3 2 2 2 2 1 2

Profit and Earnings

Profit Before Tax 3 3 2 2 4 0 -3 -6 2 2 1 1 1
Tax 1 1 1 1 1 0 0 -2 1 1 0 0 1
Net Profit 2 2 2 1 3 0 -3 -4 2 1 1 1 1
EPS 3.00 2.82 2.19 1.59 4.61 0.30 -3.74 -5.58 2.30 1.93 1.28 1.04 1.27

Choksi Laboratories Cash Flow Screener - Liquidity Fundamentals

Screen CHOKSILA cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹8.

Over the same period, investing activities used ₹7 and financing activities used ₹1.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 8 12 12 8 8 6 3 7 6 7
Investing Activities -7 -8 -7 -1 -3 -8 -14 -10 -5 -2

Financing and Net Cash

Financing Activities -1 -4 -5 -8 -5 2 11 2 -1 -5
Net Cash Flow 0 0 0 0 0 0 0 -1 0 0

Choksi Laboratories Shareholding Pattern Screener

See Choksi Laboratories shareholding pattern with promoter, FII, and DII holdings. Check Choksi Laboratories promoter holding and ownership changes for CHOKSILA on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 31.48%, foreign institutions 6.03%, domestic institutions 0.00% and the public 49.44%, spread across 4,011 shareholders.

The shareholder count was 4,011 in 2026-Mar, compared with 3,945 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 31.48% 31.48% 31.48% 31.48% 31.48% 31.48% 31.48% 31.48%

Institutional Investors

FII Holding 6.03% 7.02% 10.01% 1.94% 4.31% 5.69% 5.69% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 49.44% 49.42% 47.96% 52.67% 49.58% 48.77% 49.07% 60.01%
Other Holding 13.05% 12.08% 10.54% 13.92% 14.63% 14.05% 13.76% 8.51%
Shareholder Count 4,011 3,945 3,829 4,162 4,167 4,067 4,057 4,187

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Choksi Laboratories. Choksi Laboratories dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Choksi Laboratories.

Choksi Laboratories Stock Index Membership - Nifty & Sensex

See which indices include Choksi Laboratories stock. Check CHOKSILA index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Choksi Laboratories is not part of any tracked indices.
Only major market indices are tracked in our system.

Choksi Laboratories Market Events Screener - Corporate Actions

Get Choksi Laboratories corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Choksi Laboratories stock events that may affect CHOKSILA share price, along with derivatives, futures and options activity and sector gainers.

14 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Extraordinary General Meeting dated October 17, 2026 and Annual General Meeting dated September 18, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA -1.44%
2026-10-17 2026-10-17 Extraordinary General Meeting NA 2.17%
2026-09-18 2026-09-18 Annual General Meeting NA 73.44%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -5.22%
2026-05-25 2026-05-25 Quarterly Result Announcement NA 27.88%
2026-02-07 2026-02-07 Quarterly Result Announcement NA -3.31%
2025-11-14 2025-11-14 Quarterly Result Announcement NA -5.25%
2025-09-16 2025-09-16 Annual General Meeting NA -12.03%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 14.87%
2025-06-07 2025-06-07 Quarterly Result Announcement NA 28.65%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -0.27%
2025-02-14 2025-02-14 Quarterly Result Announcement NA 0.44%
2024-11-14 2024-11-14 Quarterly Result Announcement NA 9.28%
2024-09-21 2024-09-21 Annual General Meeting NA 13.51%

Choksi Laboratories Competitors Screener - Peer Stocks Comparison

Screen CHOKSILA competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Healthcare sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Apollo Hospitals 124,050 52.40 25,420 15.58% 2,003 57.80
Max Healthcare Institute 94,615 66.60 8,536 18.82% 1,442 62.55
Manipal Health Enterprises 87,499 98.70 10,521 25.80% 917 55.29
Aster DM Quality Care 63,719 111.60 4,769 11.25% 427 54.92
Fortis Healthcare 58,305 54.40 9,179 16.93% 1,064 46.04
Global Health 38,908 63.80 4,509 19.56% 554 68.03
Narayana Hrudayalaya 38,328 44.30 7,996 43.43% 811 56.24
Dr. Lal Path Labs 33,232 56.90 2,864 12.11% 510 56.83
Krishna Institute of Medical Sciences 30,717 155.60 3,931 28.16% 242 54.48
Syngene International 17,800 96.50 3,809 2.56% 317 68.00

Choksi Laboratories Company Announcements - News & Reports Screener

Screen CHOKSILA latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated November 21, 2026.

The next most recent announcements are dated November 21, 2026 and November 13, 2026.

Date Update Actions
2026-11-21 Submission Of Financial Result For The Quarter And Half Year Ended 30.09.2026 -
2026-11-21 Board Meeting Outcome for Meeting Of Board Of Directors Held On 14.11.2026 -
2026-11-13 Board Meeting Intimation for Meeting Of Board Of Directors Of The Company To Be Held On 14.11.2026 -
2026-11-03 Intimation Under Regulation 30 Of SEBI (LODR) 2015 Regarding Inspection Of USFDA -
2026-10-21 Clarification On Delay In Submission With Respect To Proceedings Of Extra-Ordinary General Meeting Held On October 17 2026 -
2026-10-19 Announcement under Regulation 30 (LODR)-Preferential Issue -
2026-10-19 Shareholder Meeting / Postal Ballot-Scrutinizer"s Report -
2026-10-18 Shareholder Meeting / Postal Ballot-Outcome of EGM -
2026-10-05 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-09-26 Closure of Trading Window -
2026-09-25 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-24 Intimation For Extra-Ordinary General Meeting Of The Company To Be Held On 17Th October 2026 At 12:30 P.M. Via Virtual Mode -
2026-09-19 Announcement Under Regulation 30- Preferential Issue -
2026-09-19 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-19 Board Meeting Outcome for Outcome Of Board Meeting Dated 19Th September 2026 -
2026-09-18 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-14 Board Meeting Intimation for Board Meeting Dated 19.09.2026 -
2026-08-27 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-27 Intimation For Dispatch Of Letter To Those Shareholders Whose E-Mail Addresses Are Not Registered With Company/Registrar & Transfer Agent/Depository Participants -
2026-08-25 Reg. 34 (1) Annual Report. -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹180.00, within a 52-week range of ₹89.65 to ₹219.30. The P/E ratio is 64.10 and the P/B ratio is 5.41, with earnings per unit of ₹2.82. Market capitalisation stands at ₹135.10 Cr. The company operates in the Healthcare sector, in the Healthcare Services industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 22, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.